Catalyst Wire Dossier Catalyst Wire Dossier

CMV antigen–targeted peptide vaccine

CMV peptide vaccine · University of Florida
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMV antigen–targeted peptide vaccine, covering 2014-01-14 to 2014-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens [Phase 1]

See pricing